 |
Redaporfin |
|---|---|
| Trade Name | |
| Orphan Indication | Bile duct cancer |
| USA Market Approval | USA |
| USA Designation Date | 2017-04-12 00:00:00 |
| Sponsor | Luzitin, S.A.;Edificio Bluepharma, S Martinho do Bispo;Coimbra |
| |
Redaporfin |
|---|---|
| Trade Name | |
| Orphan Indication | Bile duct cancer |
| USA Market Approval | USA |
| USA Designation Date | 2017-04-12 00:00:00 |
| Sponsor | Luzitin, S.A.;Edificio Bluepharma, S Martinho do Bispo;Coimbra |